NCT06546410View on ClinicalTrials.gov

OASIS: RetrOspective Analysis on EEGs for Identifying Seizure Susceptibility in paediatrIcs Using biomarkerS

Not yet recruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

July 1, 2025

Study Completion Date

January 1, 2026

Conditions
EpilepsyEpilepsy in Children
Interventions
DEVICE

BioEP

All patient's EEG will have the BioEP score conducted on it

Sponsors

Lead Sponsor

Neuronostics Ltd
All Listed Sponsors
lead

Neuronostics Ltd

INDUSTRY

NCT06546410 - OASIS: RetrOspective Analysis on EEGs for Identifying Seizure Susceptibility in paediatrIcs Using biomarkerS | Biotech Hunter | Biotech Hunter